Mutations in PTCH1 - frequent in BCC - or arsenic-induced impairment of GLI3 repressor formation may result in constitutive activation of the pathway and unregulated cell proliferation [1-3]. The gene discussed is PTCH1; the disease is skin basal cell carcinoma.